{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T07:03:42Z","timestamp":1784271822977,"version":"3.55.0"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jdcr.2026.04.056","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T23:30:18Z","timestamp":1778023818000},"page":"198-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Refractory chronic lymphocytic leukemia\u2013associated pruritus successfully treated with nemolizumab"],"prefix":"10.1016","volume":"73","author":[{"given":"Ian A.","family":"Sellars","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5872-523X","authenticated-orcid":false,"given":"Yash","family":"Jani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jdcr.2026.04.056_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ejp.760","article-title":"Malignancy-associated pruritus","volume":"20","author":"Rowe","year":"2016","journal-title":"Eur J Pain"},{"issue":"10","key":"10.1016\/j.jdcr.2026.04.056_bib2","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/ddg.14830","article-title":"S2k guideline: diagnosis and treatment of chronic pruritus","volume":"20","author":"St\u00e4nder","year":"2022","journal-title":"J Dtsch Dermatol Ges"},{"issue":"9","key":"10.1016\/j.jdcr.2026.04.056_bib3","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jdcr.2019.07.026","article-title":"Eosinophilic dermatosis of hematologic malignancy responding to dupilumab in a patient with chronic lymphocytic leukemia","volume":"5","author":"Jin","year":"2019","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jdcr.2026.04.056_bib4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jdcr.2024.01.003","article-title":"A case of dupilumab used to treat the exaggerated response to insect bites in the setting of chronic lymphocytic leukemia","volume":"45","author":"Guo","year":"2024","journal-title":"JAAD Case Rep"},{"issue":"1","key":"10.1016\/j.jdcr.2026.04.056_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12948-021-00148-7","article-title":"IL-31, itch and hematological malignancies","volume":"19","author":"Di Salvo","year":"2021","journal-title":"Clin Mol Allergy"},{"issue":"3","key":"10.1016\/j.jdcr.2026.04.056_bib6","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jaci.2017.10.045","article-title":"IL-31: a new key player in dermatology and beyond","volume":"141","author":"Ba\u011fci","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"17","key":"10.1016\/j.jdcr.2026.04.056_bib7","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa2301333","article-title":"Phase 3 trial of nemolizumab in patients with prurigo nodularis","volume":"389","author":"Kwatra","year":"2023","journal-title":"N Engl J Med"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626002572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626002572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:15:21Z","timestamp":1784268921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512626002572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":7,"alternative-id":["S2352512626002572"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.04.056","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Refractory chronic lymphocytic leukemia\u2013associated pruritus successfully treated with nemolizumab","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.04.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}